These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Biocompatible implants for the sustained zero-order release of narcotic antagonists. Abrahams RA; Ronel SH J Biomed Mater Res; 1975 May; 9(3):355-66. PubMed ID: 1176491 [TBL] [Abstract][Full Text] [Related]
5. The development of sustained action preparations of narcotic antagonists. Willette RE NIDA Res Monogr; 1976 Sep; (9):31-4. PubMed ID: 1004531 [No Abstract] [Full Text] [Related]
6. Background on animal testing in the drug delivery systems program. Dewey WL NIDA Res Monogr; 1981; 28():69-76. PubMed ID: 6791014 [TBL] [Abstract][Full Text] [Related]
7. Narcotic antagonists: the search for long-acting preparations: introduction. Willette RE Natl Inst Drug Abuse Res Monogr Ser; 1975; (4):1-5. PubMed ID: 827708 [No Abstract] [Full Text] [Related]
15. Long acting porous microparticle for pulmonary protein delivery. Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275 [TBL] [Abstract][Full Text] [Related]
16. [Withdrawal programmes for narcotics addicts in the USA]. Neudek K Munch Med Wochenschr; 1970 May; 112(22):1054-6. PubMed ID: 4987316 [No Abstract] [Full Text] [Related]
17. Narcotic antagonists in the treatment of opiate dependence. Fink M; Zaks A; Resnick RB; Freedman AM Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):455-8. PubMed ID: 5566728 [No Abstract] [Full Text] [Related]
18. An improved long-acting delivery system for narcotic antagonists. Misra AL; Pontani RB J Pharm Pharmacol; 1978 May; 30(5):325-6. PubMed ID: 26754 [No Abstract] [Full Text] [Related]
19. Viscosity of polymer solution phase and other factors controlling the dissolution of theophylline microspheres prepared by the emulsion solvent evaporation method. Obeidat WM; Price JC J Microencapsul; 2003; 20(1):57-65. PubMed ID: 12519702 [TBL] [Abstract][Full Text] [Related]
20. Behavioral and morphine-antagonist effects of the optical isomers of pentazocine and cyclazocine. McMillan DE; Harris LS J Pharmacol Exp Ther; 1972 Mar; 180(3):269-79. PubMed ID: 5012778 [No Abstract] [Full Text] [Related] [Next] [New Search]